Oncolytics gets FDA feedback on colorectal cancer trial expansion
Go back to Oncolytics gets FDA feedback on colorectal cancer trial expansion| Oncolytics Biotech, Inc. (NASDAQ: ONCY) | Delayed: 0.77 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.77 | 52 Week High | $1.37 | |||
| Open | $0.78 | 52 Week Low | $0.24 | |||
| Day High | $0.78 | P/E | N/A | |||
| Day Low | $0.76 | EPS | $0.00 | |||
| Volume | 491,901 | |||||
